Bleomycin in Testicular Cancer: Will Pharmacogenomics Improve Treatment Regimens? (Englisch)
- Neue Suche nach: Bokemeyer, C.
- Neue Suche nach: Bokemeyer, C.
In:
JOURNAL OF CLINICAL ONCOLOGY
;
26
, 11
;
1783-1785
;
2008
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Bleomycin in Testicular Cancer: Will Pharmacogenomics Improve Treatment Regimens?
-
Beteiligte:Bokemeyer, C. ( Autor:in )
-
Erschienen in:JOURNAL OF CLINICAL ONCOLOGY ; 26, 11 ; 1783-1785
-
Verlag:
- Neue Suche nach: W B SAUNDERS CO
-
Erscheinungsdatum:01.01.2008
-
Format / Umfang:3 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.99
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.99 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 26, Ausgabe 11
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1774
-
Monoclonal Antibodies in Cancer Therapy: 25 Years of ProgressOldham, R.K. / Dillman, R.O. et al. | 2008
- 1778
-
The ``Other'' Signaling of Trastuzumab: Antibodies Are Immunocompetent DrugsGianni, L. et al. | 2008
- 1781
-
Defining the Optimal Schedule of Drug Administration: Art or Science?Twelves, C.J. et al. | 2008
- 1783
-
Bleomycin in Testicular Cancer: Will Pharmacogenomics Improve Treatment Regimens?Bokemeyer, C. et al. | 2008
- 1786
-
Perioperative Risks of Bevacizumab and Other Biologic Agents for Hepatectomy: Theoretical or Evidence Based?Bilchik, A.J. / Hecht, J.R. et al. | 2008
- 1789
-
Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu-Positive Metastatic Breast CancerMusolino, A. / Naldi, N. / Bortesi, B. / Pezzuolo, D. / Capelletti, M. / Missale, G. / Laccabue, D. / Zerbini, A. / Camisa, R. / Bisagni, G. et al. | 2008
- 1797
-
Phase I Study of a Novel Capecitabine Schedule Based on the Norton-Simon Mathematical Model in Patients With Metastatic Breast CancerTraina, T.A. / Theodoulou, M. / Feigin, K. / Patil, S. / Tan, K.L. / Edwards, C. / Dugan, U. / Norton, L. / Hudis, C. et al. | 2008
- 1803
-
Occult Axillary Node Metastases in Breast Cancer Are Prognostically Significant: Results in 368 Node-Negative Patients With 20-Year Follow-UpTan, L.K. / Giri, D. / Hummer, A.J. / Panageas, K.S. / Brogi, E. / Norton, L. / Hudis, C. / Borgen, P.I. / Cody, H.S. et al. | 2008
- 1810
-
Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a TaxaneBurstein, H.J. / Elias, A.D. / Rugo, H.S. / Cobleigh, M.A. / Wolff, A.C. / Eisenberg, P.D. / Lehman, M. / Adams, B.J. / Bello, C.L. / DePrimo, S.E. et al. | 2008
- 1817
-
Variation in Bleomycin Hydrolase Gene Is Associated With Reduced Survival After Chemotherapy for Testicular Germ Cell Cancerde Haas, E.C. / Zwart, N. / Meijer, C. / Nuver, J. / Boezen, H.M. / Suurmeijer, A.J.H. / Hoekstra, H.J. / van der Steege, G. / Sleijfer, D.T. / Gietema, J.A. et al. | 2008
- 1824
-
Toremifene Improves Lipid Profiles in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase III StudySmith, M.R. / Malkowicz, S.B. / Chu, F. / Forrest, J. / Sieber, P. / Barnette, K.G. / Rodriquez, D. / Steiner, M.S. et al. | 2008
- 1830
-
Bevacizumab, Capecitabine, and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal CancerGruenberger, B. / Tamandl, D. / Schueller, J. / Scheithauer, W. / Zielinski, C. / Herbst, F. / Gruenberger, T. et al. | 2008
- 1836
-
Effect of Molecular Therapeutics on Liver Regeneration in a Murine ModelVan Buren, G. / Yang, A.D. / Dallas, N.A. / Gray, M.J. / Lim, S.J. / Xia, L. / Fan, F. / Somcio, R. / Wu, Y. / Hicklin, D.J. et al. | 2008
- 1843
-
Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Espanol de Tratamiento en Hematologia Pediatric-Based Protocol ALL-96Ribera, J.-M. / Oriol, A. / Sanz, M.-A. / Tormo, M. / Fernandez-Abellan, P. / del Potro, E. / Abella, E. / Bueno, J. / Parody, R. / Bastida, P. et al. | 2008
- 1850
-
Risk of Subsequent Solid Tumors After Non-Hodgkin's Lymphoma: Effect of Diagnostic Age and Time Since DiagnosisHemminki, K. / Lenner, P. / Sundquist, J. / Bermejo, J.L. et al. | 2008
- 1858
-
Involved-Field Radiotherapy Before High-Dose Therapy and Autologous Stem-Cell Rescue in Diffuse Large-Cell Lymphoma: Long-Term Disease Control and ToxicityHoppe, B.S. / Moskowitz, C.H. / Filippa, D.A. / Moskowitz, C.S. / Kewalramani, T. / Zelenetz, A.D. / Yahalom, J. et al. | 2008
- 1865
-
Lack of Community Insurance and Mammography Screening Rates Among Insured and Uninsured WomenPagan, J.A. / Asch, D.A. / Brown, C.J. / Guerra, C.E. / Armstrong, K. et al. | 2008
- 1871
-
Phase I and Pharmacokinetic Study of Daily Oral AZD2171, an Inhibitor of Vascular Endothelial Growth Factor Tyrosine Kinases, in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small-Cell Lung Cancer: The National Cancer Institute of Canada Clinical Trials GroupLaurie, S.A. / Gauthier, I. / Arnold, A. / Shepherd, F.A. / Ellis, P.M. / Chen, E. / Goss, G. / Powers, J. / Walsh, W. / Tu, D. et al. | 2008
- 1879
-
Phase III Trial Comparing Carboplatin, Paclitaxel, and Bexarotene With Carboplatin and Paclitaxel in Chemotherapy-Naive Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer: SPIRIT IIBlumenschein, G.R. / Khuri, F.R. / von Pawel, J. / Gatzemeier, U. / Miller, W.H. / Jotte, R.M. / Le Treut, J. / Sun, S.-L. / Zhang, J.K. / Dziewanowska, Z.E. et al. | 2008
- 1886
-
Randomized Phase III Trial Comparing Bexarotene (L1069-49)/Cisplatin/Vinorelbine With Cisplatin/Vinorelbine in Chemotherapy-Naive Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer: SPIRIT IRamlau, R. / Zatloukal, P. / Jassem, J. / Schwarzenberger, P. / Orlov, S.V. / Gottfried, M. / Pereira, J.R. / Temperley, G. / Negro-Vilar, R. / Rahal, S. et al. | 2008
- 1893
-
Improvement in Oncology Practice Performance Through Voluntary Participation in the Quality Oncology Practice InitiativeJacobson, J.O. / Neuss, M.N. / McNiff, K.K. / Kadlubek, P. / Thacker, L.R. / Song, F. / Eisenberg, P.D. / Simone, J.V. et al. | 2008
- 1899
-
Compassionate Approval Process for Experimental Gene-Based ProductsWallraven, G. / Nemunaitis, J.J. / Maples, P.B. et al. | 2008
- 1900
-
Could the Efficacy of Docetaxel in Prostate Cancer Patients Be Potentiated by Concomitant High-Dose Calcitriol Administration?Berruti, A. / Tucci, M. / Mosca, A. / Ardine, M. / Poggio, M. / Saini, A. / Russo, L. / Vana, F. / Dogliotti, L. et al. | 2008
- 1903
-
No Evidence for Taxane/Platinum Pharmacogenetic Markers: Just Lack of Power?Vach, W. / Bergmann, T.K. / Brosen, K. et al. | 2008
- 1905
-
Treatment of Venous Thrombosis in Patients With Intracranial MalignanciesAtkins, C.D. et al. | 2008
- 1906
-
Low Platelet Counts in Cancer Patients: Should Heparin for Venous Thromboembolism Prophylaxis Be Instituted?Singh, N.K. / Sangwan, G. et al. | 2008
- 1907
-
Capecitabine and Irinotecan As First-Line Treatment of Advanced Colorectal CancerPunt, C.J.A. / Koopman, M. et al. | 2008
- 1909
-
Contralateral Prophylactic Mastectomy: Mind the GeneticsBriasoulis, E. / Roukos, D.H. et al. | 2008